This company listing is no longer active
38G Stock Overview
Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Sproutly Canada Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.011 |
| 52 Week High | CA$0.037 |
| 52 Week Low | CA$0.0005 |
| Beta | 0.40 |
| 1 Month Change | 0% |
| 3 Month Change | 16.67% |
| 1 Year Change | -51.16% |
| 3 Year Change | -91.53% |
| 5 Year Change | n/a |
| Change since IPO | -97.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 38G | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -4.2% | -1.7% |
| 1Y | -51.2% | -32.1% | -0.2% |
Return vs Industry: 38G underperformed the German Pharmaceuticals industry which returned -14.1% over the past year.
Return vs Market: 38G underperformed the German Market which returned -22.2% over the past year.
Price Volatility
| 38G volatility | |
|---|---|
| 38G Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 38G has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 38G's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Arup Sen | www.sproutly.ca |
Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and edibles markets in Canada. It offers its products under the Caliber brand. The company is based in Vancouver, Canada.
Sproutly Canada Inc. Fundamentals Summary
| 38G fundamental statistics | |
|---|---|
| Market cap | €5.32m |
| Earnings (TTM) | -€9.68m |
| Revenue (TTM) | €374.75k |
14.3x
P/S Ratio-0.5x
P/E RatioIs 38G overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 38G income statement (TTM) | |
|---|---|
| Revenue | CA$533.55k |
| Cost of Revenue | CA$774.88k |
| Gross Profit | -CA$241.33k |
| Other Expenses | CA$13.54m |
| Earnings | -CA$13.79m |
Last Reported Earnings
Nov 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.036 |
| Gross Margin | -45.23% |
| Net Profit Margin | -2,583.86% |
| Debt/Equity Ratio | -141.1% |
How did 38G perform over the long term?
See historical performance and comparison